Efficacy of YKP3089 in Patients With Photosensitive Epilepsy

NCT00616148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: YKP3089
DRUG: Placebo

Sponsor

SK Life Science, Inc.

Collaborators

[object Object]